Promising Breakthrough in Rare Disease Treatment by PaxMedica
PaxMedica's recent FDA Type-B meeting marks a significant milestone in the treatment of a rare but fatal disease.
PaxMedica's recent FDA Type-B meeting marks a significant milestone in the treatment of a rare but fatal disease.